.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Johnson and Johnson
Cipla
Accenture
Fuji
Mallinckrodt
McKesson
Citi
Baxter
McKinsey

Generated: June 27, 2017

DrugPatentWatch Database Preview

Details for Biologics License Application 125387

« Back to Dashboard

Summary for BLA: 125387

Tradename:
EYLEA
Applicant:
Regeneron Pharmaceuticals
Ingredient:
aflibercept
Patents:40
Approval Date:Nov 18, 2011
Suppliers: see list1
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Inventors Patent Expiration Status Orphan Source
Regeneron Pharmaceuticals
EYLEA
aflibercept
INJECTABLE; INJECTION1253870012011-11-187,070,959 Regeneron Pharmaceuticals, Inc. (Tarrytown, NY) Papadopoulos; Nicholas J. (Lagrangeville, NY), Davis; Samuel (New York, NY), Yancopoulos; George D. (Yorktown Heights, NY) ► SubscribeRXcompany
Regeneron Pharmaceuticals
EYLEA
aflibercept
INJECTABLE; INJECTION1253870012011-11-187,303,746 Regeneron Pharmaceuticals, Inc. (Tarrytown, NY) Wiegand; Stanley J. (Croton on Hudson, NY), Papadopoulos; Nicholas (LaGrangeville, NY), Yancopoulos; George D. (Yorktown Heights, NY) ► SubscribeRXcompany
Regeneron Pharmaceuticals
EYLEA
aflibercept
INJECTABLE; INJECTION1253870012011-11-187,303,747 Regeneron Pharmaceuticals, Inc. (Tarrytown, NY) Wiegand; Stanley J. (Croton-on-Hudson, NY), Papadopoulos; Nicholas J. (LaGrangeville, NY), Yancopoulos; George D. (Yorktown Heights, NY), Fandl; James P. (LaGrangeville, NY), Daly; Thomas J. (New City, NY) ► SubscribeRXcompany
Regeneron Pharmaceuticals
EYLEA
aflibercept
INJECTABLE; INJECTION1253870012011-11-187,306,799 Regeneron Pharmaceuticals, Inc. (Tarrytown, NY) Wiegand; Stanley J. (Croton on Hudson, NY), Papadopoulos; Nicholas J. (LaGrangeville, NY), Yancopoulos; George D. (Yorktown Heights, NY), Fandl; James P. (LaGrangeville, NY), Daly; Thomas J. (New City, NY) ► SubscribeRXcompany
Regeneron Pharmaceuticals
EYLEA
aflibercept
INJECTABLE; INJECTION1253870012011-11-187,374,757 Regeneron Pharmaceuticals, Inc. (Tarrytown, NY) Papadopoulos; Nicholas J. (Lagrangeville, NY), Davis; Samuel (New York, NY), Yancopoulos; George D. (Yorktown Heights, NY) ► SubscribeRXcompany
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
US Army
Dow
Medtronic
Julphar
Healthtrust
Colorcon
Moodys
Mallinckrodt
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot